• LAST PRICE
    0.3600
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    0.3013/ 171
  • Ask / Lots
    0.3600/ 25
  • Open / Previous Close
    --- / 0.3600
  • Day Range
    ---
  • 52 Week Range
    Low 0.2820
    High 1.5000
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
Table Data Not Available
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesBICX
BioCorRx Inc
4.6M
-0.7x
---
United StatesMYNZ
Mainz Biomed NV
4.6M
-0.2x
---
United StatesNIVF
NewGenIvf Group Ltd
5.5M
-2.6x
---
United StatesMDCE
Medical Care Technologies Inc
5.6M
0.0x
---
United StatesMITI
Mitesco Inc
3.3M
-0.5x
---
United StatesCMPD
CompuMed Inc
5.3M
-29.1x
---
As of 2024-11-22

Company Information

BioCorRx Inc., through its subsidiaries, develops and provides addiction treatment solutions for the treatment of substance use and other related disorders. Its Beat Addiction Recovery is a substance use disorder recovery program that typically includes its Cognitive Behavioral Therapy (CBT) modules along with peer support via mobile app along with medication prescribed by an independent treating physician under their discretion. The UnCraveRx Weight Loss Program is also a medication-assisted weight loss program that includes access to concierge on-demand wellness specialists, nutritionists, fitness experts, and personal support from behavioral experts. The Company, through its subsidiary, BioCorRx Pharmaceuticals Inc., is engaged in the development of BICX104, a subcutaneous implantable naltrexone pellet for the treatment of both opioid and alcohol use disorders. It is also engaged in the establishment of alcoholism and opioid addiction rehabilitation and treatment centers.

Contact Information

Headquarters
2390 East Orangewood Avenue, Suite 500ANAHEIM, CA, United States 92806
Phone
714-462-4880
Fax
---

Executives

President, Director
Louis Lucido
President, Chief Financial Officer, Treasurer, Director
Lourdes Felix
Executive Vice President
Thomas Welch
Independent Director
Kent Emry
Independent Director
Joseph Galligan

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$4.6M
Revenue (TTM)
$26.6K
Shares Outstanding
12.7M
BioCorRx Inc does not pay a dividend.
Beta
0.63
EPS
$-0.52
Book Value
$-1.13
P/E Ratio
-0.7x
Price/Sales (TTM)
172.5
Price/Cash Flow (TTM)
---
Operating Margin
-18,579.59%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.